Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough



Rating:

Share or cite this content

Citations should be made in the following way:
J. Juanola Pla (Mataró, Spain), R. Boixeda Viu (Mataró, Spain), I. Moreno Hernandez (Vilassar de Dalt, Spain), M. De La Torre Terron (Mataró, Spain), M. Bartolomé Regué (Mataró, Spain), A. Serrano Fores (Mataró, Spain), A. Montero Rodriguez (Mataró, Spain), E. Palomera Fanegas (Mataró, Spain), M. Serra Prat (Mataró, Spain), J. Almirall Pujol (Mataró, Spain). Immunoglobulin G and subclasses in COPD exacerbator phenotype: levels in exacerbation time and clinical stability. 3115

Member's Comments

No comment yet.

Related content which might interest you: Adenovirus-specific immunoglobulin G maturation in acute exacerbations of COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Levels of immunoglobulins of classes A and G in saliva in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 586s Year: 2005 Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function Source: Annual Congress 2007 - Mechanisms of airway inflammation Year: 2007 The frequent exacerbator phenotype in asthma: a clinical characterization Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020 COPD: Plasma surfactant protein-D (SPD) concentration as a predictor of acute exacerbations (AE) probability Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 IgG immunoglobulin levels and the frequency of respiratory infections in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 543s Year: 2002 Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E Source: Eur Respir J 2010; 35: 757-760 Year: 2010 COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015 Plasma surfactant protein D (SP-D) in patients (pts) with stable (S) COPD and during COPD acute exacerbation (AE) Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Study on the relation between serum complement (C3, C4) levels and acute exacerbations in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study Source: ERJ Open Res, 4 (3) 00022-2018; 10.1183/23120541.00022-2018 Year: 2018 Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Comparison of airway T cell phenotypes in COPD and severe asthma: the influence of smoking Source: Eur Respir J 2005; 26: Suppl. 49, 23s Year: 2005 COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Increased interferon and decreased NRF2-PPARG signaling is associated with frequent exacerbations in COPD Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Surfactant protein D (SPD) like marker of effectiveness in patients (pts) with acute exacerbations (AE) of COPD ofphosphatidylcholine treatment outcomes Source: International Congress 2015 – Different data in COPD Year: 2015